Healthcare of Ontario Pension Plan Trust Fund Acquires Shares of 282,689 agilon health, inc. (NYSE:AGL)

Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in agilon health, inc. (NYSE:AGL - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 282,689 shares of the company's stock, valued at approximately $1,849,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.07% of agilon health at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Capital International Investors grew its holdings in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in agilon health by 46.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company's stock valued at $127,256,000 after buying an additional 3,195,087 shares during the period. AQR Capital Management LLC increased its holdings in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Wellington Management Group LLP raised its position in shares of agilon health by 2.9% in the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company's stock valued at $533,501,000 after buying an additional 1,191,253 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC bought a new stake in shares of agilon health during the 1st quarter worth approximately $2,975,000.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.20% of the stock is owned by insiders.

agilon health Trading Down 1.7 %

AGL stock traded down $0.06 during mid-day trading on Monday, reaching $3.16. The company's stock had a trading volume of 2,847,195 shares, compared to its average volume of 5,002,008. agilon health, inc. has a 12 month low of $2.99 and a 12 month high of $20.37. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The business's 50 day moving average price is $4.50 and its 200 day moving average price is $5.38. The company has a market cap of $1.30 billion, a price-to-earnings ratio of -4.59 and a beta of 0.54.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business's quarterly revenue was up 38.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.04) earnings per share. On average, equities research analysts predict that agilon health, inc. will post -0.32 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on AGL shares. Evercore ISI upped their target price on agilon health from $5.50 to $7.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft reduced their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Benchmark reissued a "buy" rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Bank of America lowered shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $8.22.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.